Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dangerous Things is a leading biohacking company that designs and manufactures implantable RFID and NFC transponders, biomagnets, and related hardware for human enhancement. Founded in 2013 by Amal Graafstra, the company focuses on providing medical-grade, biocompatible devices that allow individuals to interact with digital systems and sense magnetic fields. Their product line includes subdermal implants used for keyless entry, secure data storage, and cryptographic identity verification. Dangerous Things also fosters a global community of professional installers and biohacking enthusiasts to ensure safe implantation procedures. The company's work is central to the transhumanist movement, pushing the boundaries of human-machine integration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dangerous Things.